Similarly, another clinical trial in patients with RA reported increased LVEF and reduced serum levels of HF biomarkers, such as NT-proBNP, IL-6, and endothelin-1, following infliximab treatment, further supporting the possible cardioprotective effects of anti-TNF therapy [32]. Here, TNF is linked to hydrops fetalis.